[1]
Quintanilla, J. et al. 2022. Safety and Effectiveness of Lower Alteplase Dose Driven by Impending Clinical Deterioration Factors in very Elderly Submassive Pulmonary Embolism Patients. Case Series. Archives of Clinical and Medical Case Reports. 6, 5 (Oct. 2022), 669–678.